Millendo Therapeutics, Inc. MLND
52-week range unavailable
- Open
- 1.12
- Prev close
- 1.06
- Mkt cap
- 20.19M
- Vol
- 1.91M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.06
- High
- 1.13
- Forward P/E
- -2.26
- Beta
- 0.48
- Short ratio
- 0.98
- Inst. own
- 37.18%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 2, 2021
- 50-d avg
- 18.86
- 200-d avg
- 25.14
- 1y target
- 2.00
6M chart
Chart tools
Chart is warming up
The six-month price history for MLND has not been loaded yet. Try again in a moment.
Altman Z-Score
-35.18 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.2×
P/S 0.0×
P/B 0.7×
P/FCF 0.0×
EV/EBITDA 18.2×
EV/Sales 0.0×
FCF Yield 0.0%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -393.9%
ROIC 0.0%
ROA -155.1%
Revenue 0.0%
Operating Income 0.0%
EPS (diluted) -322.0%
Free Cash Flow 100.0%
Current Ratio 2.5×
Quick Ratio 2.5×
Debt / Equity 1.2×
Net Debt / EBITDA 1.6×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31